| Schedule of Assets and Liabilities Measured at Fair Value |
The following table sets forth the Company’s assets and liabilities that were recognized at fair value: | | | | | | | | | | | | | | | | | | | | | | | | | Quoted Prices in
Active Markets for
Identical Assets | | Significant Other
Observable
Inputs | | Significant Other
Unobservable
Inputs | | | | As of September 30, 2026 | (Level 1) | | (Level 2) | | (Level 3) | | Total | | Assets | | | | | | | | Cash equivalents - Money market funds(1) | $ | 47,238 | | | $ | — | | | $ | — | | | $ | 47,238 | | Mutual funds(1) | 127,419 | | | — | | | — | | | 127,419 | | | Derivative financial instruments | — | | | 3,500 | | | — | | | 3,500 | | | Total | $ | 174,657 | | | $ | 3,500 | | | $ | — | | | $ | 178,157 | | | Liabilities | | | | | | | | | Derivative financial instruments | $ | — | | | $ | 46,984 | | | $ | — | | | $ | 46,984 | | Contingent consideration(2) | — | | | — | | | 61,100 | | | 61,100 | | | Total | $ | — | | | $ | 46,984 | | | $ | 61,100 | | | $ | 108,084 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Quoted Prices in
Active Markets for
Identical Assets | | Significant Other
Observable
Inputs | | Significant Other
Unobservable
Inputs | | | | As of December 31, 2025 | (Level 1) | | (Level 2) | | (Level 3) | | Total | | Assets | | | | | | | | Cash equivalents - Money market funds(1) | $ | 50,971 | | | $ | — | | | $ | — | | | $ | 50,971 | | Mutual funds(1) | 129,549 | | | — | | | — | | | 129,549 | | | Derivative financial instruments | — | | | 6,064 | | | — | | | 6,064 | | | Total | $ | 180,520 | | | $ | 6,064 | | | $ | — | | | $ | 186,584 | | | Liabilities | | | | | | | | | Derivative financial instruments | $ | — | | | $ | 25,208 | | | $ | — | | | $ | 25,208 | | Contingent consideration(2) | — | | | — | | | 5,000 | | | 5,000 | | | Total | $ | — | | | $ | 25,208 | | | $ | 5,000 | | | $ | 30,208 | |
(1) Represents money market funds and short-term investments which are carried at the fair value option under ASC Topic 825, Financial Instruments.
(2) Contingent consideration is presented under “Accrued expenses and other current liabilities” and “Other non-current liabilities,” as applicable, in the consolidated balance sheets.
|
| Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation |
The following table summarizes the changes in the fair value of contingent consideration: | | | | | | | | | | | | | | | | | | | | | | | | | Three months ended September 30, | | Nine months ended September 30, | | 2026 | | 2025 | | 2026 | | 2025 | | Opening balance | $ | 8,000 | | | $ | 2,700 | | | $ | 5,000 | | | $ | 2,700 | | | Acquisition | 53,100 | | | — | | | 53,100 | | | — | | | Fair value changes | — | | | — | | | 3,000 | | | — | | | Payments | — | | | — | | | — | | | — | | | Closing balance | $ | 61,100 | | | $ | 2,700 | | | $ | 61,100 | | | $ | 2,700 | |
|